Arbutus Biopharma Corp Cash Flow Quality Index
Arbutus Biopharma Corp cash flow quality index. Arbutus Biopharma Corp (ABUS) has a Cash Flow Quality Index of -0.05x as of March 2026. Operating cash flow of $-8.11 Million is below net income of $169.69 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Arbutus Biopharma Corp to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Arbutus Biopharma Corp (2006–2012)
Cash flow quality index of Arbutus Biopharma Corp from 2006 to 2012. Historical Cash Flow Quality Index for Arbutus Biopharma Corp across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ABUS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Arbutus Biopharma Corp Cash Flow Quality Index by Year (2006–2012)
Arbutus Biopharma Corp cash flow quality index by year from 2006 to 2012. Year-by-year earnings quality comparison for Arbutus Biopharma Corp. For the full cash flow conversion analysis, see Arbutus Biopharma Corp (ABUS) cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2012 | 1.11x | $33.27 Million | $29.95 Million | ▲ +865.7% |
| 2006 | -0.15x | $-2.62 Million | $18.08 Million | — |